A New Sustained-release, 3-Month Leuprolide Acetate Formulation Achieves and Maintains Castrate Concentrations of Testosterone in Patients With Prostate Cancer

Authors:

Abstract
No abstract available
Funding Information
  • GP-Pharm S.A., Spain

This publication has 26 references indexed in Scilit: